Philippa Roxby
Philippa Roxby is a health reporter for BBC News. She covers a range of topics related to public health and medical research, with a focus on emerging infectious diseases and their impact on global populations. Prior to joining BBC News, Philippa worked as a freelance journalist for various publications, including The Guardian and The Independent. Her work has been recognized with several awards, including the UK's Medical Journalists' Association Award for Best News Article. Philippa holds a degree in English Literature from the University of Oxford and is based in London.
80%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
91%
Examples:
Conflicts of Interest
98%
Examples:
- The new strain of the mpox virus spreading quickly along the eastern border of Democratic Republic of Congo is ‘incredibly worrying’, say health officials monitoring its spread.
Contradictions
85%
Examples:
- A new strain of mpox, called mpox (clade 1b), is spreading rapidly in central Africa.[
- Mpox, formerly called monkeypox, is a viral infection and can be deadly.
Deceptions
47%
Examples:
- Global health experts say the new variant risks cross-border and international spread of the virus, with one calling it the "most dangerous strain yet".
- The virus, which can cause lesions across the whole body, is making some people very ill and can be deadly.
Recent Articles
Deadly New Mpox Strain (Clade 1b) Surges in Democratic Republic of Congo: Highest Mortality Rates, Lack of Vaccines and Treatments Pose Major Challenges
Broke On: Wednesday, 26 June 2024A deadly new strain of mpox, Clade 1b, is causing an outbreak in the Democratic Republic of Congo with over 8,600 reported cases and 410 deaths. This strain has a higher fatality rate than previous strains and is spreading through close contact. The WHO urges immediate action to address the lack of vaccines and treatments in controlling the epidemic, which primarily affects monkeys but can also infect humans. New Blood Test Predicts Parkinson's Disease Seven Years Before Symptoms Appear: A Game Changer in Early Detection
Broke On: Wednesday, 19 June 2024A new blood test using artificial intelligence identifies eight biomarkers to predict Parkinson's disease up to seven years before symptoms appear, potentially revolutionizing diagnosis and treatment of this neurodegenerative disorder. NHS England Warns Against Misuse of Weight-Loss Drugs like Ozempic and Wegovy for Achieving 'Beach Bodies'
Broke On: Thursday, 13 June 2024Britain's top doctor, Professor Sir Stephen Powis, warns against misuse of weight-loss drugs like Ozempic and Wegovy for those seeking a 'beach body'. Concerned about reports of normal weight and underweight individuals obtaining these drugs without proper checks, Sir Stephen urges caution and stresses they should only be used by those with obesity or diabetes due to potential dangerous side-effects. The surge in popularity of these drugs has led to concerns over their easy access online and through beauty clinics, resulting in young girls suffering side-effects despite not being overweight. Dengue Fever Surges in Europe: 1,500+ Imported Cases and Expanding Mosquito Range Amid Climate Change
Broke On: Tuesday, 11 June 2024Dengue fever, transmitted by the Asian tiger mosquito (aedes albopictus), is surging in Europe with 130 locally acquired cases and over 4900 imported cases reported in 2023. The disease's spread is attributed to climate change and the mosquito's presence in 13 EU/EEA countries. France, which has seen most native cases, is taking measures to monitor and trap the invasive species. The EU health commissioner urges Europe to prepare for a rise in mosquito-borne diseases due to global warming. Antidepressant Discontinuation Symptoms: Prevalence, Impact, and Management
Broke On: Thursday, 06 June 2024One in six people may experience antidepressant discontinuation symptoms (ADS) after prolonged use, including anxiety, depression, insomnia, and flu-like symptoms. The exact prevalence and impact of ADS are still debated. Factors increasing the risk include length of use, dosage, and specific antidepressants. Proper tapering under medical supervision can help minimize symptoms.